HR 8652
Dialysis-Related Amyloidosis Treatment Act of 2020
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Dialysis-Related Amyloidosis Treatment Act of 2020, aims to improve Medicare coverage for treatments specifically designed to address dialysis-related amyloidosis, a serious complication of long-term kidney dialysis. It expands Medicare’s coverage to include treatments provided in dialysis facilities and necessary supplies, and clarifies payment procedures for these specialized treatments. The bill also ensures that payments for these treatments are made at 100% of reasonable charges, separate from standard renal dialysis payments.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.